التفاصيل البيبلوغرافية
| العنوان: |
Utility of MRI in NMIBC and feasibility of avoiding Re-TURB in carefully selected patients: a systematic review. |
| المؤلفون: |
Saouli, A.1 (AUTHOR) Amine.saouli0@gmail.com, Zerda, I.2 (AUTHOR), Elkhader, K.2 (AUTHOR), Durand, X.3 (AUTHOR), Ariane, M.4 (AUTHOR), Quhal, Fahad5 (AUTHOR), Shammari, Masoud Al6 (AUTHOR), Contieri, Roberto7,8 (AUTHOR), Chebbi, Ala3,4 (AUTHOR) |
| المصدر: |
World Journal of Urology. 1/30/2025, Vol. 43 Issue 1, p1-8. 8p. |
| مصطلحات موضوعية: |
*NON-muscle invasive bladder cancer, *TRANSURETHRAL resection of bladder, *MAGNETIC resonance imaging, *REOPERATION, *DIAGNOSTIC examinations, *BIBLIOGRAPHIC databases |
| مستخلص: |
Objective: This systematic review was conducted to synthesize current research on the role of repeated transurethral resection of the bladder (re-TURB) and the emerging use of magnetic resonance imaging (MRI) in discerning patient suitability for safely foregoing this procedure. Evidence acquisition: Employing a methodical literature search, we consulted several bibliographic databases including PubMed, Science Direct, Scopus, and Embase. The review process adhered strictly to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines. Evidence synthesis: We evaluated data from 667 patients (mean age 65.8 years; age range 59–75 years) who underwent MRI prior to potential re-TURB. The gap between initial TURB and MRI was reported as 42 days in one study, while the interval between MRI and subsequent cystoscopy, with or without biopsy, varied from 21 days to 3 months. Initial TURB pathology for non-muscle invasive bladder cancer (NMIBC) patients identified stage Ta in 177 (42.5%) and T1 in 246 (57.5%) patients across three studies. High-grade and low-grade pathologic classifications were reported in 377 (64.5%) and 207 (35.5%) patients respectively in two studies. The VI-RADS scoring system's sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the detection of bladder cancer recurrence were 89%, 85.5%, 82.7%, and 96%, respectively. A total of 365 patients (54.7%) underwent re-TUR. Among NMIBC patients, re-TUR pathology revealed Ta in 22 cases (5.4%) and pT1 in 179 cases (44%) with VI-RADS 1–2, while no cases of Ta (0%) and 37 cases of T1 (9%) were reported with VI-RADS 4–5, as documented in two studies. Notably, only 69 patients (10.7%) were identified as having MIBC across all studies. Conclusion: MRI is demonstrating reliability as a diagnostic tool for non-muscle invasive bladder cancers. The VI-RADS scoring system appears to be a promising approach in selecting patients for re-TURB. DW-MRI may serve as a primary diagnostic examination for patient follow-up post-TURB. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |